Imunon, Inc. Revenue from Contract with Customer, Excluding Assessed Tax
Imunon, Inc. (IMNN) reported Revenue from Contract with Customer, Excluding Assessed Tax of $500.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-28.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2024-03-28
- Imunon, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-12-31 was $125.00K, a 0.00% change year-over-year.
- Imunon, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-09-30 was $125.00K, a 0.00% change year-over-year.
- Imunon, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-06-30 was $125.00K, a 0.00% change year-over-year.
- Imunon, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2022-03-31 was $125.00K, a 0.00% change year-over-year.
- Imunon, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $500.00K, a 0.00% change from fiscal 2021.
- Imunon, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2021 was $500.00K, a 0.00% change from fiscal 2020.
- Imunon, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2020 was $500.00K, a 0.00% change from fiscal 2019.
- Imunon, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2019 was $500.00K, a 0.00% change from fiscal 2018.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2022-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $250.00K derived: sum of 2 quarters · filed 2024-03-28 | $375.00K derived: sum of 3 quarters · filed 2024-03-28 | $500.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $125.00K 10-Q · filed 2023-11-14 | $250.00K derived: sum of 2 quarters · filed 2023-11-14 | $375.00K 10-Q · filed 2023-11-14 | $500.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $125.00K 10-Q · filed 2023-08-10 | $250.00K 10-Q · filed 2023-08-10 | $375.00K derived: sum of 3 quarters · filed 2023-08-10 | $500.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $125.00K 10-Q · filed 2023-05-11 | $250.00K derived: sum of 2 quarters · filed 2023-05-11 | $375.00K derived: sum of 3 quarters · filed 2023-05-11 | $500.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $250.00K derived: sum of 2 quarters · filed 2023-03-30 | $375.00K derived: sum of 3 quarters · filed 2023-03-30 | $500.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $125.00K 10-Q · filed 2022-11-14 | $250.00K derived: sum of 2 quarters · filed 2022-11-14 | $375.00K 10-Q · filed 2022-11-14 | $500.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $125.00K 10-Q · filed 2022-08-15 | $250.00K 10-Q · filed 2022-08-15 | $375.00K derived: sum of 3 quarters · filed 2022-08-15 | $500.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $125.00K 10-Q · filed 2022-05-16 | $250.00K derived: sum of 2 quarters · filed 2022-05-16 | $375.00K derived: sum of 3 quarters · filed 2022-05-16 | $500.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $250.00K derived: sum of 2 quarters · filed 2022-03-31 | $375.00K derived: sum of 3 quarters · filed 2022-03-31 | $500.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $125.00K 10-Q · filed 2021-11-15 | $250.00K derived: sum of 2 quarters · filed 2021-11-15 | $375.00K 10-Q · filed 2021-11-15 | $500.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $125.00K 10-Q · filed 2021-08-12 | $250.00K 10-Q · filed 2021-08-12 | $375.00K derived: sum of 3 quarters · filed 2021-08-12 | $500.00K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $125.00K 10-Q · filed 2021-05-14 | $250.00K derived: sum of 2 quarters · filed 2021-05-14 | $375.00K derived: sum of 3 quarters · filed 2021-05-14 | $500.00K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $250.00K derived: sum of 2 quarters · filed 2021-03-19 | $375.00K derived: sum of 3 quarters · filed 2021-03-19 | $500.00K 10-K · filed 2021-03-19 |
| 2019-09-30 | $125.00K 10-Q · filed 2020-11-16 | $250.00K derived: sum of 2 quarters · filed 2020-11-16 | $375.00K 10-Q · filed 2020-11-16 | $500.00K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $125.00K 10-Q · filed 2020-08-14 | $250.00K 10-Q · filed 2020-08-14 | $375.00K derived: sum of 3 quarters · filed 2020-08-14 | $500.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $125.00K 10-Q · filed 2020-05-15 | $250.00K derived: sum of 2 quarters · filed 2020-05-15 | $375.00K derived: sum of 3 quarters · filed 2020-05-15 | $500.00K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $250.00K derived: sum of 2 quarters · filed 2020-03-25 | $375.00K derived: sum of 3 quarters · filed 2020-03-25 | $500.00K 10-K · filed 2020-03-25 |
| 2018-09-30 | $125.00K 10-Q · filed 2019-11-14 | $250.00K derived: sum of 2 quarters · filed 2019-11-14 | $375.00K 10-Q · filed 2019-11-14 | $500.00K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $125.00K 10-Q · filed 2019-08-14 | $250.00K 10-Q · filed 2019-08-14 | $375.00K derived: sum of 3 quarters · filed 2019-08-14 | $500.00K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $125.00K 10-Q · filed 2019-05-15 | $250.00K derived: sum of 2 quarters · filed 2019-05-15 | $375.00K derived: sum of 3 quarters · filed 2019-05-15 | $500.00K derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $250.00K derived: sum of 2 quarters · filed 2019-03-29 | $375.00K derived: sum of 3 quarters · filed 2019-03-29 | $500.00K 10-K · filed 2019-03-29 |
| 2017-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $250.00K derived: sum of 2 quarters · filed 2018-11-14 | $375.00K 10-Q · filed 2018-11-14 | |
| 2017-06-30 | $125.00K 10-Q · filed 2018-11-14 | $250.00K 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |